Resultado de búsqueda
Leading experts from multiple disciplines address the anatomy and chemistry of the frontal cortex, neuropsychological assessments of capabilities unique to the frontal lobes, the nature of (and possible treatment avenues for) frontotemporal dementia and related conditions, and implications for understanding and treating neuropsychiatric disorders, such as schizophrenia, mania, and depression.
This syndrome most closely approximates the “frontal lobe personality” assumed by many to occur after injury to the frontal lobes. Tranel [ 5 ] and Damasio et al . [ 2 ] studied the localization of stroke, head trauma, or neoplasm-induced lesions in patients with acquired sociopathy.
1 de abr. de 2006 · " The frontal lobes and neuropsychiatric illness." The Journal of Neuropsychiatry and Clinical Neurosciences, 6(4), pp. 341–477. Access content To read the fulltext, please use one of the options below to sign in or purchase access. Personal login Institutional Login; Sign in via ...
29 de ene. de 2024 · Long-Term Effects. Treatment. Trauma or injury to the frontal lobe of your brain can cause a wide range of problems and changes to your personality. That’s because the frontal lobe is responsible for shaping social behavior and personal characteristics. It controls things such as personality, decision-making, motivation, and voluntary movements.
30 de may. de 2001 · This volume brings together the latest work in clinical neuropsychiatry, neuropsychology, neuroscience, and neuroimaging. Part 1 introduces frontal lobe dysfunc
22 de nov. de 2019 · Sultzer et al. first demonstrated hypometabolism in the frontal lobes in AD subjects with higher psychosis factor score on the NRS (Sultzer et al., 1995). Hirono et al. found increased left inferior temporal gyrus and decreased left medial occipital metabolism in 26 subjects with predominantly moderate-severe AD (Hirono et al., 1998b).
1 de abr. de 2006 · Neuropsychiatric disorders of frontal-subcortical circuits include impaired executive function, disinhibition, and apathy; indicative mood disorders include depression, mania, and lability. Transmitters, modulators, receptor subtypes, and second messengers within the circuits provide a chemoarchitecture that can inform pharmacotherapy.
